RENAISSANCE TECHNOLOGIES LLC

Position in DSGN — Design Therapeutics, Inc.

CIK 1037389 NEW YORK, NY

Position in DSGN

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$4,343,248

+$1,650,250 QoQ

Shares Held

408,200

+42.2% QoQ

Ownership

0.654%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,450,872,574 across 330 Biotechnology names. DSGN ranks #90 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,726,993	$588,750,729
2	INCY	Incyte Corp	3,651,532	$343,682,191
3	CORT	Corcept Therapeutics Inc	5,682,783	$229,072,982
4	VRTX	Vertex Pharmaceuticals Inc / Ma	421,688	$188,300,559
5	JAZZ	Jazz Pharmaceuticals plc	819,374	$154,902,654
6	GMAB	Genmab A/S	4,414,550	$118,442,376
7	INVA	Innoviva, Inc.	4,055,632	$94,496,225
8	ARWR	Arrowhead Pharmaceuticals, Inc.	1,036,495	$64,988,236

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,343,248	408,200	+42.2%	Shares	Sole	2026-05-14
2025-12-31	$2,692,998	287,100	+4.7%	Shares	Sole	2026-02-12
2025-09-30	$2,065,479	274,300	+2.4%	Shares	Sole	2025-11-13
2025-06-30	$902,486	267,800	+1.1%	Shares	Sole	2025-08-13
2025-03-31	$1,022,900	265,000	+4.5%	Shares	Sole	2025-05-14
2024-12-31	$1,564,095	253,500	-7.5%	Shares	Sole	2025-02-13
2024-09-30	$1,474,120	274,000	-28.7%	Shares	Sole	2024-11-13
2024-06-30	$1,286,651	384,075	-15.3%	Shares	Sole	2024-08-09
2024-03-31	$1,827,202	453,400	-30.1%	Shares	Sole	2024-05-13
2023-12-31	$1,719,320	648,800	+295.1%	Shares	Sole	2024-02-13
2023-09-30	$387,512	164,200	+72.6%	Shares	Sole	2023-11-14
2023-06-30	$599,180	95,108	-6.5%	Shares	Sole	2023-08-11
2023-03-31	$587,103	101,751	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.